Retrieve available abstracts of 217 articles: HTML format
Single Articles
August 2025
NEWSOME SD, Krzystanek E, Selmaj KW, Dufek M, et al Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the
Phase 3 OCARINA II Study.
Neurology. 2025;105:e213909. PubMed
July 2025
WU L, Jiang W, Du R, Liu Y, et al Clinical Reasoning: Acute and Progressive Cognitive Decline in a 38-Year-Old Man.
Neurology. 2025;105:e213871. PubMedAbstract available
PETERSSON M, Jons D, Feresiadou A, Ilinca A, et al Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the
Swedish Nationwide GEMG Study.
Neurology. 2025;105:e213771. PubMedAbstract available
ZHOU J, Nilius S, Pilipczuk O, Scowcroft A, et al Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United
States: A Cohort Study Using Health Care Claims Databases.
Neurology. 2025;105:e213736. PubMedAbstract available
JIA A, Price TR, Rosner J, Broderick C, et al Journal Club: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year
Nationwide Retrospective Cohort Study.
Neurology. 2025;105:e213663. PubMedAbstract available
June 2025
GOYNE C, Fair AE, Yilmaz D, Race J, et al Epigenetic Aging in Pediatric-Onset Multiple Sclerosis.
Neurology. 2025;104:e213673. PubMedAbstract available
JUL JARBAEK NIELSEN J, Levison L, Andersen H Mortality in Myasthenia Gravis in Denmark From 1985 to 2020: A Population-Based
Cohort Study.
Neurology. 2025;104:e213745. PubMedAbstract available
YEH EA Accelerated Aging in Children With Multiple Sclerosis: Can We Stop the Clock?
Neurology. 2025;104:e213840. PubMed
KRIJNEN EA, Jelgerhuis J, Van Dam M, Bouman PM, et al Evolution of Cortical Lesions and Function-Specific Cognitive Decline in People
With Multiple Sclerosis.
Neurology. 2025;104:e213650. PubMedAbstract available
May 2025
VAN NEDERPELT DR, Bos L, Mattiesing RM, Strijbis EMM, et al Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease
Severity.
Neurology. 2025;104:e213618. PubMedAbstract available
LANGER-GOULD A, Li BH, Smith JB, Kanter MH, et al Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment
Algorithm at the Health System Level.
Neurology. 2025;104:e213607. PubMedAbstract available
KAPPOS L, Yiu S, Dahlke F, Coetzee T, et al Composite Confirmed Disability Worsening/Progression Is a Useful Clinical
Endpoint for Multiple Sclerosis Clinical Trials.
Neurology. 2025;104:e213558. PubMedAbstract available
FOX RJ, Rudick RA A Newly Validated Gold Standard for Measuring Multiple Sclerosis Disability
Worsening.
Neurology. 2025;104:e213672. PubMed
DINOTO A, Cacciaguerra L, Vorasoot N, Redenbaugh V, et al Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin
Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Neurology. 2025;104:e213557. PubMedAbstract available
VU AP, Kapadia RK, Roberts JI Pearls & Oy-sters: Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
Presenting as Encephalomyelitis With Leptomeningeal Enhancement.
Neurology. 2025;104:e213662. PubMedAbstract available
MARRIE RA, Sharma M, Cutter GR, Fox RJ, et al Perspectives of People With Multiple Sclerosis Regarding Data Linkage and
Sharing.
Neurology. 2025;104:e213587. PubMedAbstract available
CHAGGAR G, Waldner D, Scozzafava J, Harrison R, et al Teaching NeuroImage: Severe Enterovirus Encephalitis as a Complication of
Ocrelizumab Treatment for Multiple Sclerosis.
Neurology. 2025;104:e213585. PubMed
NEWSOME SD, Krzystanek E, Selmaj KW, Dufek M, et al Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the
Phase 3 OCARINA II Study.
Neurology. 2025;104:e213574. PubMedAbstract available
ZARA P, Chessa P, Deiana GA, Morette AM, et al Risk of False Acetylcholine Receptor Autoantibody Positivity by
Radioimmunoprecipitation Assay in Clinical Practice.
Neurology. 2025;104:e213498. PubMedAbstract available
GUINEBRETIERE O, Pierret C, Calonge Q, Januel E, et al Updated Multiple Sclerosis Incidence in France, 2011-2021.
Neurology. 2025;104:e213586. PubMedAbstract available
April 2025
ZELIKOVICH AS, Zamorska B, Michaelson NM Patient Perspectives: Patient as Teacher: The Impact of Listening to a Patient
With Stiff-Person Syndrome on Her Disease Course.
Neurology. 2025;104:e213433. PubMedAbstract available
NAKAJIMA A, Hokari M, Yanagimura F, Saji E, et al Long-Term Clinical Landscapes of Spinal Hypertrophic Pachymeningitis With
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Neurology. 2025;104:e213420. PubMedAbstract available
AL-SALAHAT A, Abdul Jabbar AB, Sharma R, Chen YT, et al Demographic and Geographic Trends in Myasthenia Gravis-Related Mortality in the
United States, 1999-2022.
Neurology. 2025;104:e213505. PubMedAbstract available
ABBOUD H, Clardy SL, Dubey D, Wickel J, et al The Clinical Trial Landscape in Autoimmune Encephalitis: Challenges and
Opportunities.
Neurology. 2025;104:e213487. PubMedAbstract available
BROWNLEE WJ, Foster MA, Pontillo G, Davagnanam I, et al Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing
Multiple Sclerosis.
Neurology. 2025;104:e210274. PubMedAbstract available
GANESH A, Galetta SL Editors' Note: Domestic Violence and Abuse in People Living With Multiple
Sclerosis.
Neurology. 2025;104:e213407. PubMed
VIDAL-JORDANA A, Ontaneda D To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis.
Neurology. 2025;104:e213416. PubMed
MAHAJAN KR, Herman D, Zheng Y, Androjna C, et al Neurodegeneration and Demyelination in the Multiple Sclerosis Spinal Cord:
Clinical, Pathological, and 7T MRI Perspectives.
Neurology. 2025;104:e210259. PubMedAbstract available
MAVRIDIS A, Viktorisson A, Eliasson B, von Euler M, et al Risk of Ischemic and Hemorrhagic Stroke in Individuals With Type 1 and Type 2
Diabetes: A Nationwide Cohort Study in Sweden.
Neurology. 2025;104:e213480. PubMedAbstract available
MCAREE M, Frontera JA Clinical Reasoning: A 56-Year-Old Woman With New-Onset Hoarseness and Dysphagia.
Neurology. 2025;104:e213363. PubMedAbstract available
March 2025
GOH WGW, Ng IKS, Tan MKX, Fong CYK, et al Clinical Reasoning: A 26-Year-Old Woman With Headache and Eosinophilia.
Neurology. 2025;104:e213434. PubMedAbstract available
MAILLART E, Dubessy AL, Shor N, Piljan M, et al Severe Relapse After Switching From Eculizumab to Satralizumab in Neuromyelitis
Optica Spectrum Disorder.
Neurology. 2025;104:e213399. PubMedAbstract available
GOMEZ-FIGUEROA E, Moreno-Bernardino CJ, De Alba-Sanchez AM, Guerrero-Udave N, et al The Burden of Multiple Sclerosis in Mexico.
Neurology. 2025;104:e213343. PubMedAbstract available
February 2025
TRANFA M, Petracca M, Moccia M, Scaravilli A, et al Conventional MRI-Based Structural Disconnection and Morphometric Similarity
Networks and Their Clinical Correlates in Multiple Sclerosis.
Neurology. 2025;104:e213349. PubMedAbstract available
MARRIE RA, Bolton J, Ling YV, Bernstein C, et al Peripartum Mental Illness in Mothers With Multiple Sclerosis and Other Chronic
Diseases in Ontario, Canada.
Neurology. 2025;104:e210170. PubMedAbstract available
DERSCH RS, Fingerle V, Berns J, Rauer S, et al Pearls & Oy-sters: Recurrent Lyme Neuroborreliosis With Seroreversion in a
Patient With Multiple Sclerosis on a B-Cell Depleting Therapy.
Neurology. 2025;104:e213330. PubMedAbstract available
ROSS LA Peripartum Mental Illness in Mothers With Multiple Sclerosis Merits Neurologists'
Attention.
Neurology. 2025;104:e213366. PubMed
CERQUEIRA JJ, Berthele A, Cree BAC, Filippi M, et al Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS:
Nine-Year Data From the OPERA Studies Open-Label Extension.
Neurology. 2025;104:e210142. PubMedAbstract available
COBO-CALVO A, Carbonell-Mirabent P, Tur C, Otero-Romero S, et al Age-Related Disability Outcomes After a First Demyelinating Event.
Neurology. 2025;104:e210305. PubMedAbstract available
KRYSKO KM, Waltz M, Chitnis T, Weinstock-Guttman B, et al Study of the Association Between Menarche and Disease Course in Pediatric
Multiple Sclerosis.
Neurology. 2025;104:e210213. PubMedAbstract available
ROCCA MA, Preziosa P, Filippi M Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From
Clinical Onset.
Neurology. 2025;104:e213396. PubMed
BRENTON JN Menarche and Relapses in Multiple Sclerosis: Associations Between a Physiologic
Developmental Milestone and Disease Activity.
Neurology. 2025;104:e213321. PubMed
BALCOM EF, Mccombe JA, Kate MP, Vu K, et al Inequities in the Use of Disease-Modifying Therapy Among Adults Living With
Multiple Sclerosis in Urban and Rural Areas in Alberta, Canada.
Neurology. 2025;104:e210251. PubMedAbstract available
CARVAJAL R, Guananga-Alvarez D, Tur C, Esperalba J, et al Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on
Seroprotection Rates Against Hepatitis B Virus in People With MS.
Neurology. 2025;104:e210281. PubMedAbstract available
AMEZCUA L, Cardenas-Iniguez C, Orlando C, Martinez A, et al Person-Centered Social Determinants and Neighborhood-Level Deprivation Associated
With Disability in Hispanic People With Multiple Sclerosis.
Neurology. 2025;104:e213332. PubMedAbstract available
Randomized Phase 2 Study of FcRn Antagonist Efgartigimod in Generalized
Myasthenia Gravis.
Neurology. 2025;104:e210299. PubMed
Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test.
Neurology. 2025;104:e210298. PubMed
January 2025
TSAI CC, Chen J, Pikula A, Johnson EL, et al Opinion & Special Articles: Beyond Pronouns-Educating Trainees on the Impact of
Language on Gender Inclusivity in Neurologic Practice.
Neurology. 2025;104:e210289. PubMedAbstract available
SILVERMAN HE, Bostrom A, Nylander AN, Akula A, et al Association of Menopause With Functional Outcomes and Disease Biomarkers in Women
With Multiple Sclerosis.
Neurology. 2025;104:e210228. PubMedAbstract available
SALTER A, Lancia S, Cutter GR, Fox RJ, et al Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple
Sclerosis.
Neurology. 2025;104:e210149. PubMedAbstract available
CARVALHO IV, Gomes F, Almendra L, Geraldo A, et al Reversible Unilateral Tongue Border Atrophy Associated With Anti-Acetylcholine
Receptor Antibody-Positive Myasthenia Gravis.
Neurology. 2025;104:e210288. PubMed
CAGOL A, Montobbio N Reassuring Insights Into the Effect of COVID-19 on Symptoms and Disability in
People With Multiple Sclerosis: Weathering the Storm.
Neurology. 2025;104:e210272. PubMed
CRUCIANI A, Toosy AT Progression Independent of Relapse Activity in Multiple Sclerosis: More, or Less,
Than Meets the Eye?
Neurology. 2025;104:e210296. PubMed
STRIJBIS EMM, Mostert J, Comtois J, Salter A, et al Utility of Progression Independent of Relapse Activity as a Trial Outcome in
Relapsing-Remitting Multiple Sclerosis.
Neurology. 2025;104:e210153. PubMedAbstract available
WONG SH, Abuzaitoun R, Cornblath WT, Eggenberger ER, et al Multicenter Validation of the Ocular Myasthenia Gravis Rating Scale
Questionnaire.
Neurology. 2025;104:e210150. PubMedAbstract available
MONGAY-OCHOA N, Pareto D, Alberich M, Carbonell-Mirabent P, et al Association of the Cervical Canal Area With Disability and Progression in People
With Multiple Sclerosis.
Neurology. 2025;104:e210136. PubMedAbstract available
CHEN B, Francis A, Cooper SA, Dobson R, et al Quantitative Contribution of Clinical Attacks to Residual Disability in Patients
With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder.
Neurology. 2025;104:e210137. PubMedAbstract available
JUL JARBAEK NIELSEN J, Levison L, Andersen H Changes in Myasthenia Gravis Incidence in Denmark From 1985 to 2021: A Nationwide
Population-Based Study.
Neurology. 2025;104:e210139. PubMedAbstract available
December 2024
RIMKUS CM, Nucci MP, Avolio IB, Apostolos-Pereira SL, et al Atrophy Patterns in Patients With Multiple Sclerosis With Cognitive Impairment,
Fatigue, and Mood Disorders.
Neurology. 2024;103:e210080. PubMedAbstract available
BRENNER J, Ruhe CJ, Kulderij I, Bastiaansen AEM, et al Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With
Anti-NMDAR Encephalitis.
Neurology. 2024;103:e210109. PubMedAbstract available
SIRIRATNAM P, Huda S, Van Der Walt A, Sanfilippo PG, et al Prevalence of Progression Independent of Relapse Activity and Relapse-Associated
Worsening in Patients With AQP4-IgG-Positive NMOSD.
Neurology. 2024;103:e209940. PubMedAbstract available
ROSS R, O'Neill KA, Betensky RA, Billiet T, et al Association of Social Determinants of Health With Brain MRI Outcomes in
Individuals With Pediatric Onset Multiple Sclerosis.
Neurology. 2024;103:e210140. PubMedAbstract available
HARTUNG HP, Benedict RHB, Berger T, Bermel RA, et al Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb
ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.
Neurology. 2024;103:e210049. PubMedAbstract available
CRANE PD, Sillau S, Dreher R, Fix R, et al Population-Based Study of the Epidemiology of Stiff Person Syndrome in a Large
Colorado-Based Health System.
Neurology. 2024;103:e210078. PubMedAbstract available
KLEIN CJ, Triplett JD, Murray DL, Gorsh AP, et al Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for
Neuropathy Treatment Evaluation.
Neurology. 2024;103:e210000. PubMedAbstract available
QUINN CM, Rajarajan P, Gill AJ, Kopinsky H, et al Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune
Checkpoint Inhibitors for Oncologic Indications.
Neurology. 2024;103:e210003. PubMedAbstract available
WILSON E, Meeks HD, Barney BJ, Waltz M, et al Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis
in the United States.
Neurology. 2024;103:e209991. PubMedAbstract available
November 2024
REEVES JA, Bartnik A, Jakimovski D, Mohebbi M, et al Associations Between Paramagnetic Rim Lesion Evolution and Clinical and
Radiologic Disease Progression in Persons With Multiple Sclerosis.
Neurology. 2024;103:e210004. PubMedAbstract available
WATANABE M, Isobe N, Niino M, Nakashima I, et al Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica
Spectrum Disorder in Japan by the Fifth Nationwide Survey.
Neurology. 2024;103:e209992. PubMedAbstract available
SANTILLI AR, Ni O, Milone M, Selcen D, et al Immune-Mediated Megaconial Myopathy: A Novel Subtype of Autoimmune Myopathy.
Neurology. 2024;103:e210001. PubMedAbstract available
GUSOVSKY AV, Lin CC, Kerber K, Reynolds EL, et al Costs Are Still on the Rise for Commonly Prescribed Branded Neurologic
Medications.
Neurology. 2024;103:e210029. PubMedAbstract available
SHARMA R, Bellacicco NJ, Husar WG, Park JH, et al Pearls & Oy-sters: Breaking Bad CIDP: Recognition of Anti-NF155 Autoimmune
Nodopathy in Refractory CIDP.
Neurology. 2024;103:e209848. PubMed
MICHAELSON NM, Klawiter EC, Singhal T Journal Club: PET Imaging in Multiple Sclerosis and Its Prognostic Implications.
Neurology. 2024;103:e210047. PubMed
PONTILLO G, Prados F, Colman J, Kanber B, et al Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep
Learning: The Brain-Predicted Disease Duration Gap.
Neurology. 2024;103:e209976. PubMedAbstract available
BRUCKMAN D, Lee I, Schold JD, Claytor BR, et al Epidemiologic Study of Myasthenia Gravis in the Elderly US Population: A
Longitudinal Analysis of the Medicare Claims Database, 2006-2019.
Neurology. 2024;103:e210005. PubMedAbstract available
Predicting Outcome in Guillain-Barre Syndrome: International Validation of the
Modified Erasmus GBS Outcome Score.
Neurology. 2024;103:e209968. PubMed
BROEDERS TAA, van Dam M, Pontillo G, Rauh V, et al Energy Associated With Dynamic Network Changes in Patients With Multiple
Sclerosis and Cognitive Impairment.
Neurology. 2024;103:e209952. PubMedAbstract available
PIERRET C, Mulliez A, Le Bihan-Benjamin C, Moisset X, et al Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide
Retrospective Cohort Study.
Neurology. 2024;103:e209885. PubMedAbstract available
GUPTA J, Choudhary R, Gupta A, Sharma P, et al Child Neurology: Acute Necrotizing Encephalopathy of Childhood Associated With
Dengue: Good Neurologic Outcome Despite a Fulminant Presentation.
Neurology. 2024;103:e209954. PubMedAbstract available
SIEGLER JE, Galetta SL Editors' Note: Teaching NeuroImage: Anti-NMDA Receptor Encephalitis Presenting
With Cerebellitis in a Pediatric Patient.
Neurology. 2024;103:e209934. PubMed
MOEHLMAN M Author Response: Teaching NeuroImage: Anti-NMDA Receptor Encephalitis Presenting
With Cerebellitis in a Pediatric Patient.
Neurology. 2024;103:e209565. PubMed
YANG Y, Li J, Tang Y Reader Response: Teaching NeuroImage: Anti-NMDA Receptor Encephalitis Presenting
With Cerebellitis in a Pediatric Patient.
Neurology. 2024;103:e209545. PubMed
MARIGNIER R, Kunchok A Eculizumab in AQP4-IgG NMOSD: Efficacy in the Real World and Potential Warning of
Meningococcal Vaccines.
Neurology. 2024;103:e209970. PubMed
RINGELSTEIN M, Asseyer S, Lindenblatt G, Fischer K, et al Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care
Data From a European Cohort.
Neurology. 2024;103:e209888. PubMedAbstract available
October 2024
SILVERMAN A, Sasaki M, Espindola Lima JE, Cheronis C, et al Child Neurology: Remarkable Recovery From Severe Acute Necrotizing
Encephalopathy.
Neurology. 2024;103:e209877. PubMedAbstract available
SIEGLER JE 3RD, Galetta S Editors' Note: Investigating the Prevalence of Comorbidity in Multiple Sclerosis
Clinical Trial Populations.
Neurology. 2024;103:e209893. PubMed
GROBOIS L, You M, Etienne M Reader Response: Investigating the Prevalence of Comorbidity in Multiple
Sclerosis Clinical Trial Populations.
Neurology. 2024;103:e209508. PubMed
SALTER A, Lancia S, Kowalec K, Fitzgerald KC, et al Author Response: Investigating the Prevalence of Comorbidity in Multiple
Sclerosis Clinical Trial Populations.
Neurology. 2024;103:e209515. PubMed
HAY M, Rollot F, Casey R, Kerbrat A, et al Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple
Sclerosis: A Multicenter Real-Life Study.
Neurology. 2024;103:e209886. PubMedAbstract available
YOKOTE H, Mori K, Nakamichi K, Matsuda T, et al Global Hyperperfusion in the Brain at Onset of the Immune Reconstitution
Inflammatory Syndrome in a Patient With Natalizumab-Associated PML.
Neurology. 2024;103:e209874. PubMed
ROBERTS JI, Ng D, Kapadia R Pearls & Oy-sters: Tumour-Like Mass Lesion Secondary to Primary CNS Vasculitis.
Neurology. 2024;103:e209819. PubMedAbstract available
Patient and Physician Perspectives on the Wearing-Off Effect in Multiple
Sclerosis: Results From Structured Interviews (P1-6.015).
Neurology. 2024;103:e209905. PubMed
Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis:
A Swedish Nationwide Study.
Neurology. 2024;103:e209461. PubMed
LOONSTRA FC, Alvarez Sirvent D, Tesi N, Holstege H, et al Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple
Sclerosis in a Population-Based Birth-Year Cohort.
Neurology. 2024;103:e209663. PubMedAbstract available
BLACKOWICZ M, James J, McNeil-Posey K, Schwartz T, et al Socioeconomic Factors Associated with >/=2-year Delayed Diagnosis of Neuromyelitis
Optica Spectrum Disorder (NMOSD) in the United States.
Neurology. 2024;103. PubMedAbstract available
MANGIORIS G, Orozco E, Dubey D, Flanagan E, et al Long-Term Outcomes in Antibody-Negative Autoimmune Encephalitis: A Retrospective
Study.
Neurology. 2024;103. PubMedAbstract available
VENKATARAMAN I, Ott A, Miske R, Scharf M, et al Performance Assessment of the New EUROLINE Neurologic Syndrome 15 Ag (IgG) for
the Determination of Autoantibodies Associated with Neurological Disorders.
Neurology. 2024;103. PubMedAbstract available
ROVIRA A, Pareto D chi-Separation as a Novel MRI Biomarker for Assessing Disease Progression in
Multiple Sclerosis: Divide and Conquer.
Neurology. 2024;103:e209735. PubMed
MULLER J, Lu PJ, Cagol A, Ruberte E, et al Quantifying Remyelination Using chi-Separation in White Matter and Cortical
Multiple Sclerosis Lesions.
Neurology. 2024;103:e209604. PubMedAbstract available
BOURDETTE D Investigating When Patients With Multiple Sclerosis Should Switch From a Low- or
Moderate-Efficacy Therapy to a High-Efficacy Treatment.
Neurology. 2024;103:e209835. PubMed
BSTEH G, Aicher ML, Walde JF, Krajnc N, et al Association of Disease-Modifying Treatment With Outcome in Patients With
Relapsing Multiple Sclerosis and Isolated MRI Activity.
Neurology. 2024;103:e209752. PubMedAbstract available
BANKS SA, Brinjikji W, Giannini C, Syc-Mazurek SB, et al Intra-arterial Melphalan as Targeted Therapy for Tumefactive Multiple Sclerosis
Lesions.
Neurology. 2024;103:e209739. PubMed
ZARA P, Solla P, Damato V, Sechi E, et al Teaching Video NeuroImage: The "Chameleon Eyes Sign" in Myasthenia Gravis.
Neurology. 2024;103:e209756. PubMed
SHIMIZU A, Noguchi-Shinohara M, Komatsu J, Ono K, et al Multifocal Intracranial Rosai-Dorfman Disease Mimicking Immunoglobulin G4-Related
Pachymeningitis.
Neurology. 2024;103:e209741. PubMed
ABBOUD H, Farez MF The Risk of Multiple Sclerosis Relapse After Vaccination: Can a Population-Based
Study of Mass Vaccination End the Longstanding Debate?
Neurology. 2024;103:e209761. PubMed
MOISSET X, Leray E, Chenaf C, Taithe F, et al Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis
in France: A Self-Controlled Case Series.
Neurology. 2024;103:e209662. PubMedAbstract available
August 2024
KARALIUS M, Mohan S, Paredes D, Rasool N, et al Pearls & Oy-sters: Optic Neuritis as First Demyelinating Event During Pregnancy
in 2 Young Hispanic Women: MS vs MOGAD.
Neurology. 2024;103:e209706. PubMedAbstract available
PASCUAL-GONI E, Caballero-Avila M, Querol L Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test.
Neurology. 2024;103:e209725. PubMedAbstract available
MENON D, Alharbi M, Katzberg HD, Bril V, et al Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular
Myasthenia Gravis: A Retrospective Cohort Study.
Neurology. 2024;103:e209722. PubMedAbstract available
TAGA A, Wali A, Eberhart CG, Green KE, et al Teaching NeuroImage: Giant Cell Arteritis With Optic Perineuritis.
Neurology. 2024;103:e209707. PubMed
WANG W Reader Response: Partially Reversible FLAIR Hyperintensity Along the Brainstem
Surface in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
Neurology. 2024;103:e209441. PubMed
WU J, Guo K, Liu J Author Response: Partially Reversible FLAIR Hyperintensity Along the Brainstem
Surface in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
Neurology. 2024;103:e209463. PubMed
LEWIS A, Galetta SL Editors' Note: Partially Reversible FLAIR Hyperintensity Along the Brainstem
Surface in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
Neurology. 2024;103:e209736. PubMed
Characterization Profiles of ANCA-associated Vasculitis With Neurological
Manifestations (P7-14.007).
Neurology. 2024;103:e209640. PubMed
Artificial Intelligence-Based Ocular Motor Biomarkers for Myasthenia Gravis
Diagnosis (P10-11.016).
Neurology. 2024;103:e209639. PubMed
MAYCOCK TJ, Rossor T, Vanegas M, Gringras P, et al Child Neurology: Common Occurrence of Narcolepsy Type 1 and Myasthenia Gravis.
Neurology. 2024;103:e209598. PubMedAbstract available
SASTRE-GARRIGA J, Vidal-Jordana A, Toosy AT, Enzinger C, et al Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS
Position Paper and Future Perspectives.
Neurology. 2024;103:e209677. PubMedAbstract available
WILLIAMS MJ, Amezcua L, Cohan SL, Cohen JA, et al Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From
Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.
Neurology. 2024;103:e209610. PubMedAbstract available
July 2024
PFEUFFER S, Wolff S, Aslan D, Rolfes L, et al Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis
Patients Older Than 50 Years.
Neurology. 2024;103:e209574. PubMedAbstract available
GRANGEON L, Boulouis G, Capron J, Bala F, et al Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary
Angiitis of the CNS: A Comparative Study.
Neurology. 2024;103:e209548. PubMedAbstract available
GAVAZZI F, Vaia Y, Woidill S, Formanowski B, et al Nonverbal Cognitive Skills in Children With Aicardi Goutieres Syndrome.
Neurology. 2024;103:e209541. PubMedAbstract available
CICCARELLI O, Barkhof F, Calabrese M, De Stefano N, et al Using the Progression Independent of Relapse Activity Framework to Unveil the
Pathobiological Foundations of Multiple Sclerosis.
Neurology. 2024;103:e209444. PubMedAbstract available
MADSEN MA, Povazan M, Wiggermann V, Lundell H, et al Association of Cortical Lesions With Regional Glutamate, GABA, N-Acetylaspartate,
and Myoinositol Levels in Patients With Multiple Sclerosis.
Neurology. 2024;103:e209543. PubMedAbstract available
June 2024
KAMINSKI HJ, Kusner LL, Cutter GR, Le Panse R, et al Does Surgical Removal of the Thymus Have Deleterious Consequences?
Neurology. 2024;102:e209482. PubMedAbstract available
PALLADINO R, Monasta L Estimating the Prevalence and Burden of Multiple Sclerosis in China Using the
Global Burden of Disease Study: Challenges and Future Directions.
Neurology. 2024;102:e209521. PubMed
ZHANG C, Liu W, Wang L, Wang F, et al Prevalence and Burden of Multiple Sclerosis in China, 1990-2019: Findings From
the Global Burden of Disease Study 2019.
Neurology. 2024;102:e209351. PubMedAbstract available
May 2024
CACCIAGUERRA L, Abdel-Mannan O, Champsas D, Mankad K, et al Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG
Antibody-Associated Disease.
Neurology. 2024;102:e209303. PubMedAbstract available
SILBERMANN E, Spain RI Serum Neurofilament Light Chain for Multiple Sclerosis Relapses: Too Little Too
Late?
Neurology. 2024;102:e209456. PubMed
FOX RJ, Cree BAC, de Seze J, Gold R, et al Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic
Disease Activity in Patients With Multiple Sclerosis.
Neurology. 2024;102:e209357. PubMedAbstract available
VALKO Y, Wirth MA, Fierz FC, Schesny MK, et al Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose
Myasthenia Gravis in Patients With Ptosis or Diplopia.
Neurology. 2024;102:e209395. PubMedAbstract available
LIAO J, Lu Y, Lu Y, Huang Y, et al Cardiopulmonary Coupling Spectrogram as an Ambulatory Method for Assessing Sleep
Disorders in Patients With Autoimmune Encephalitis.
Neurology. 2024;102:e209302. PubMedAbstract available
MICHAELSON NM Right Brain: The Unraveling.
Neurology. 2024;102:e209492. PubMedAbstract available
VYAS MV, Kapral MK, Alonzo R, Fang J, et al Proportion of Life Spent in Canada and the Incidence of Multiple Sclerosis in
Permanent Immigrants.
Neurology. 2024;102:e209350. PubMedAbstract available
TANG A, Yoshida K, Lahey H, Wilcox DR, et al Herpes Simplex Virus Encephalitis in Patients With Autoimmune Conditions or
Exposure to Immunomodulatory Medications.
Neurology. 2024;102:e209297. PubMedAbstract available
April 2024
ZOUVELOU V, Petrou EM, Strataki E, Vasileiou V, et al Pearls & Oy-sters: Thyroid-Associated Ophthalmopathy and Transient Neuromuscular
Junction Disorder Due to Graves Disease.
Neurology. 2024;102:e209282. PubMedAbstract available
DEMORTIERE S, Joubert B, Benaiteau M, Hilezian F, et al Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.
Neurology. 2024;102:e209284. PubMed
MOEHLMAN M, Kornbluh AB Teaching NeuroImage: Anti-NMDA Receptor Encephalitis Presenting With Cerebellitis
in a Pediatric Patient.
Neurology. 2024;102:e209259. PubMed
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal,
Prospective, Multicenter Study.
Neurology. 2024;102:e209214. PubMed
OYAMA M, Holzer MT, Ohnuki Y, Saito Y, et al Pathologic Features of Anti-Ku Myositis.
Neurology. 2024;102:e209268. PubMedAbstract available
OLIVE-CIRERA G, Bruijstens AL, Fonseca EG, Chen LW, et al MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders.
Neurology. 2024;102:e209199. PubMedAbstract available
SPELMAN T, Simoneau G, Hyde R, Kuhelj R, et al Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in
Pediatric-Onset Multiple Sclerosis: A Registry-Based Study.
Neurology. 2024;102:e208114. PubMedAbstract available
TOGNI CL, Frontzek K, Schubring-Giese M, Imbach LL, et al Posttransplant Anti-GABA(A) Receptor Antibody-Associated Autoimmune Encephalitis.
Neurology. 2024;102:e209245. PubMed
THAKOLWIBOON S, Dubey D Redefining Patient Evaluation in Anti-IgLON5 Disease: Anti-IgLON5 Disease
Composite Score.
Neurology. 2024;102:e209213. PubMed
GAIG C, Gruter T, Heidbreder A, Sabater L, et al Development of a Composite Score for the Clinical Assessment of Anti-IgLON5
Disease.
Neurology. 2024;102:e208101. PubMedAbstract available
KOTHAPALLI NP, Chompoopong P, McKeon A, Dubey D, et al Teaching Video NeuroImage: Adaptor-Related Protein-Complex-3 Subunit beta-2
Immunoglobulin-G-Associated Autoimmune Ataxia.
Neurology. 2024;102:e209257. PubMed
AGYEI P, Chen M, Guo Y, Perez CA, et al Pearls & Oy-sters: KLHL11 IgG Paraneoplastic-Associated Hearing Loss and
Rhombencephalitis in a Woman With Metastatic Mullerian Tumor.
Neurology. 2024;102:e209187. PubMedAbstract available
KUHLMANN G, Cloud B Characterization of the Earliest Adopters of Subcutaneous FcRn Blockers for gMG
(P4-14.013).
Neurology. 2024;102. PubMedAbstract available
YU Y, Kushlaf H Multiple Sclerosis in a Patient with Friedreich's Ataxia (P4-6.016).
Neurology. 2024;102. PubMedAbstract available
MASCANFRONI I, Manasson J, Pellerin A, Sanmarco L, et al Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving
Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases (P4-14.018).
Neurology. 2024;102. PubMedAbstract available
WATANABE F, Fedorko J, Imitola J Dimethyl Fumarate Enhances Neural Stem Cell (NSC) Self-renewal and
Neuroprotection in a Human Cellular Model of Multiple Sclerosis
Inflammation-induced Neurodegeneration (P8-6.014).
Neurology. 2024;102. PubMedAbstract available
OHRN S, Patel R, Ali A, Bauerschmidt A, et al Autonomic Dysfunction in Autoimmune Encephalitis: A Review of the Literature
(P6-14.004).
Neurology. 2024;102. PubMedAbstract available
ZAJNER C, Patil N, McInnis R, Van Uum S, et al Patterns of Extraocular Muscle Enlargement in Graves' Disease and Acromegaly
(P7-10.005).
Neurology. 2024;102. PubMedAbstract available
ROBERTS K, Cohn B, Sista SR Acetylcholine Binding Receptor Positivity from Passive Antibody Transfer in a
Case of Progressive Muscular Atrophy (P11-11.009).
Neurology. 2024;102. PubMedAbstract available
WEBER A, Rose J, DeWitt L NMOSD: Previously Seropositive Patient Presents with Seronegative Brainstem
Attack (P11-14.017).
Neurology. 2024;102. PubMedAbstract available
LOBAINA M, Valaparla VL, Shanina E Vogt-Koyanagi-Harada Disease an Autoimmune Comorbidity of Multiple Sclerosis, Not
Just a Mimicker (P3-14.014).
Neurology. 2024;102. PubMedAbstract available
HABIB AA, Kaminski HJ, Grosskreutz J, Mantegazza R, et al Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness
Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder
Rate in the MycarinG study (P4-11.001).
Neurology. 2024;102. PubMedAbstract available
KARAYI G, Quinones-Herrero N, Martin J, Chaudhry S, et al A Retrospective Analysis of Disease Modifying Drug Discontinuation in Patients
with Multiple Sclerosis (S31.010).
Neurology. 2024;102. PubMedAbstract available
ROSE M, Hsu S, Balan A, Anderson A, et al Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study
(P4-6.014).
Neurology. 2024;102. PubMedAbstract available
JAFFRY K, Karpenos S, Lin J, Matos J, et al Climate Change Associated with Declining Clinical Outcomes in Myasthenia Gravis
for US States with the Greatest Temperature Increase (P4-14.004).
Neurology. 2024;102. PubMedAbstract available
MAKAROVA A, Raju S, Ciotti J Parainfectious Hemorrhagic Longitudinally-extensive Transverse Myelitis Secondary
to COVID-19 (P1-13.010).
Neurology. 2024;102. PubMedAbstract available
WOODSON S, Gettings E, Guo CY, Klineova S, et al Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with
Multiple Sclerosis Treated with Fumarates (P4-6.005).
Neurology. 2024;102. PubMedAbstract available
VARNET M, Kayani S, Wang C Diagnostic Journey and Therapeutic Intervention of a Type-1 Interferonopathy in a
Newborn (P6-8.002).
Neurology. 2024;102. PubMedAbstract available
MIKAMI T, Levy M Association of HLA-DRB1*15:01 Status with Transcriptomic Pattern of B cells in
CSF in Multiple Sclerosis (P7-6.011).
Neurology. 2024;102. PubMedAbstract available
March 2024
YOUNG A, Johnston JL Pearls & Oy-sters: Ocular Myasthenia Gravis: Central Ocular Motor Signs and
Unilateral Visual Loss Caused by the Great Neuro-Ophthalmologic Impersonator.
Neurology. 2024;102:e209260. PubMedAbstract available
AOTSUKA Y, Misawa S, Suichi T, Shibuya K, et al Prevalence, Clinical Profiles, and Prognosis of CIDP in Japanese Nationwide
Survey: Analyses of 1,257 Diagnosis-Confirmed Patients.
Neurology. 2024;102:e209130. PubMedAbstract available
MARRIE RA, Salter A Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials.
Neurology. 2024;102:e208099. PubMed
LEMMENS CMC, van Amerongen S, Strijbis EM, Killestein J, et al Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy
in Patients With Multiple Sclerosis.
Neurology. 2024;102:e208032. PubMedAbstract available
BOURDETTE D, Wooliscroft L The Challenges of Treating Late-Onset Multiple Sclerosis.
Neurology. 2024;102:e209146. PubMed
MOURESAN EF, Mentesidou E, Berglund A, Mckay KA, et al Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis:
A Swedish Nationwide Study.
Neurology. 2024;102:e208051. PubMedAbstract available
Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic
Rims in Patients With Multiple Sclerosis.
Neurology. 2024;102:e209252. PubMed
SALTER A, Lancia S, Kowalec K, Fitzgerald KC, et al Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial
Populations.
Neurology. 2024;102:e209135. PubMedAbstract available
CHARD DT Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New
Perspective on an Old Foe.
Neurology. 2024;102:e209246. PubMed
ARNOLD DL, Elliott C, Martin EC, Hyvert Y, et al Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple
Sclerosis: A Post Hoc Analysis of a Phase 2 Trial.
Neurology. 2024;102:e208058. PubMedAbstract available
PAPP V, Magyari M, Moller S, Sellebjerg F, et al Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis
Optica Spectrum Disorder Patient Cohort.
Neurology. 2024;102:e209147. PubMedAbstract available
February 2024
MORGAN A, Li Y, Thompson NR, Milinovich A, et al Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With
Anti-NMDA Receptor Encephalitis.
Neurology. 2024;102:e208019. PubMedAbstract available
RADZIK AM, Amezcua L, Anderson A, Gilmore S, et al Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With
Multiple Sclerosis: A Diverse Multicenter Cohort.
Neurology. 2024;102:e208100. PubMedAbstract available
BRANCH A, Nuaaman MM, Appleton CT, Connaughton DM, et al Teaching NeuroImage: Extensive Brainstem and Striatal Involvement in
Neuropsychiatric Systemic Lupus Erythematosus.
Neurology. 2024;102:e209153. PubMed
GALBUSERA R, Bahn E, Weigel M, Cagol A, et al Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic
Rims in Patients With Multiple Sclerosis.
Neurology. 2024;102:e207966. PubMedAbstract available
WU J, Guo K, Liu J Partially Reversible FLAIR Hyperintensity Along the Brainstem Surface in
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
Neurology. 2024;102:e208064. PubMedAbstract available
NG HS, Zhu F, Zhao Y, Yao S, et al Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis.
Neurology. 2024;102:e208006. PubMedAbstract available
BELLUCCI M, Castellano C, Marinelli L, Garbarino L, et al Patient With Rigidity and Fasciculations.
Neurology. 2024;102:e208110. PubMedAbstract available
BRIDGE F, Brotherton J, Stankovich J, Sanfilippo PG, et al Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With
Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Neurology. 2024;102:e208059. PubMedAbstract available
January 2024
GIBSON S, Mcgraw C Teaching NeuroImage: Cryptococcus in a Woman With Multiple Sclerosis on
Fingolimod.
Neurology. 2024;102:e208027. PubMedAbstract available
ANTOZZI C, Guptill J, Bril V, Gamez J, et al Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia
Gravis.
Neurology. 2024;102:e207937. PubMedAbstract available
MCGINLEY MP, Harvey T, Lopez R, Ontaneda D, et al Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in
the United States.
Neurology. 2024;102:e207916. PubMedAbstract available
HABIB AA, Sacks N, Cool C, Durgapal S, et al Hospitalizations and Mortality From Myasthenia Gravis.
Neurology. 2024;102:e207863. PubMedAbstract available
LANGER-GOULD A, Sotirchos ES, Bourdette D Rituximab for Multiple Sclerosis.
Neurology. 2024;102:e208063. PubMedAbstract available
GALETTA S, Brownlee W Assignment Completed.
Neurology. 2024;102:e207913. PubMedAbstract available
TUR C, Rocca MA Progression Independent of Relapse Activity in Multiple Sclerosis.
Neurology. 2024;102:e207936. PubMedAbstract available
VIDAL-JORDANA A, Rovira A, Calderon W, Arrambide G, et al Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria.
Neurology. 2024;102:e200805. PubMedAbstract available
CAGOL A, Benkert P, Melie-Garcia L, Schaedelin SA, et al Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With
Progression Independent of Relapse Activity in People With MS.
Neurology. 2024;102:e207768. PubMedAbstract available
VLAHOVIC L, McDonald J, Hinman J, Tomczak A, et al Prevalence, Demographic, and Clinical Factors Associated With Cognitive
Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorder.
Neurology. 2024;102:e207965. PubMedAbstract available
ALKABIE S, Gray MT, Lau JC, Barra L, et al Teaching NeuroImage: Unilateral Primary Angiitis of the CNS.
Neurology. 2024;102:e208018. PubMedAbstract available
December 2023
ROLLOT F, Uhry Z, Dantony E, Vukusic S, et al Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality.
Neurology. 2023;101:e2483-e2496. PubMedAbstract available
SUNSHINE A, Mandle QJ, Cabal Herrera AM, Zapanta B, et al Pearls & Oy-sters: Leber Hereditary Optic Neuropathy-Plus Masquerading as
Neuromyelitis Optica Spectrum Disorder in a 2-Year-Old Child.
Neurology. 2023;101:e2585-e2588. PubMedAbstract available
GUINEBRETIERE O, Nedelec T, Gantzer L, Lekens BB, et al Association Between Diseases and Symptoms Diagnosed in Primary Care and the
Subsequent Specific Risk of Multiple Sclerosis.
Neurology. 2023 Dec 5:10.1212/WNL.0000000000207981. PubMedAbstract available
November 2023
LI X, Stitt D, Lanzino G, Giannini C, et al Teaching NeuroImage: Pachymeningitis and Aortitis as the Initial Presentation of
Granulomatosis With Polyangiitis.
Neurology. 2023;101:979-980. PubMed
October 2023
SRIVASTAVA I, Van Haren K Immunotherapy in Autoimmune Encephalitis: So Many Options, So Few Guidelines.
Neurology. 2023 Oct 25:10.1212/WNL.0000000000208026. PubMed
BOURDETTE D, Silbermann E What Are the Risks of Guillain-Barre Syndrome Following SARS-CoV-2 Infection and
COVID-19 Vaccination?
Neurology. 2023 Oct 18:10.1212/WNL.0000000000207998. PubMed
BISHARA H, Arbel A, Barnett-Griness O, Bloch S, et al Association Between Guillain-Barre Syndrome and COVID-19 Infection and
Vaccination: A Population-Based Nested Case-Control Study.
Neurology. 2023 Oct 18:10.1212/WNL.0000000000207900. PubMedAbstract available
YANG JH, Liu EN, Nguyen L, Dunn-Pirio A, et al Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult
Autoimmune Encephalitis.
Neurology. 2023 Oct 12:10.1212/WNL.0000000000207746. PubMedAbstract available
GUASP M, Dalmau J Searching for Neuronal Antibodies in Psychiatric Diseases: Uncertain Findings and
Implications.
Neurology. 2023;101:656-660. PubMedAbstract available
SOTIRCHOS ES, Hu C, Smith MD, Lord HN, et al Agreement Between Published Reference Resources for Neurofilament Light Chain
Levels in People With Multiple Sclerosis.
Neurology. 2023 Oct 10:10.1212/WNL.0000000000207957. PubMedAbstract available
LE VU S, Bertrand M, Botton J, Jabagi MJ, et al Risk of Guillain-Barre Syndrome Following COVID-19 Vaccines: A Nationwide
Self-controlled Case Series Study.
Neurology. 2023 Oct 3:10.1212/WNL.0000000000207847. PubMedAbstract available
September 2023
COBO-CALVO A, Tur C, Otero-Romero S, Carbonell-Mirabent P, et al Association of Very Early Treatment Initiation With the Risk of Long-term
Disability in Patients With a First Demyelinating Event.
Neurology. 2023;101:e1280-e1292. PubMedAbstract available
PALLADINO R, Strijbis EM How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical
Practice?
Neurology. 2023 Sep 25:10.1212/WNL.0000000000207989. PubMed
CHERTCOFF AS, Yusuf F, Zhu F, Evans C, et al Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple
Sclerosis.
Neurology. 2023 Sep 25:10.1212/WNL.0000000000207843. PubMedAbstract available
HUPPKE BM, Reinert M, Hummel-Abmeier H, Stark W, et al Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and
Treatment Response in Pediatric Multiple Sclerosis.
Neurology. 2023 Sep 25:10.1212/WNL.0000000000207791. PubMedAbstract available
ALMRAMHI MM, Finan C, Storm CS, Schmidt AF, et al Exploring the Role of Plasma Lipids and Statins Interventions on Multiple
Sclerosis Risk and Severity: A Mendelian Randomization Study.
Neurology. 2023 Sep 1:10.1212/WNL.0000000000207777. PubMedAbstract available
BUYUKKURT A, Harroud A The Potential to Inform Statin Use in Multiple Sclerosis Through Human Genetics
[re: WNL-2023-000524].
Neurology. 2023 Sep 1:10.1212/WNL.0000000000207773. PubMed
July 2023
QUINN C, Moulton K, Farwell M, Le W, et al Imaging With PET/CT of Diffuse CD8 T Cell Infiltration of Skeletal Muscle in
Patients with Inclusion Body Myositis.
Neurology. 2023 Jul 24:10.1212/WNL.0000000000207596. PubMedAbstract available
COUSTAL C, Goulabchand R, Labauge P, Guilpain P, et al Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency
With Neurologic Involvement.
Neurology. 2023 Jul 24:10.1212/WNL.0000000000207609. PubMedAbstract available
SCHWEITZER F, Laurent S, Cortese I, Fink GR, et al Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and
Potential Biomarkers of Response to Therapy.
Neurology. 2023 Jul 24:10.1212/WNL.0000000000207622. PubMedAbstract available
September 2022
B SYC-MAZUREK S, Chen JJ, Morris P, Sechi E, et al Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in
Patients With MOG-Antibody-Associated Disease.
Neurology. 2022 Sep 29. pii: WNL.0000000000201263. PubMedAbstract available
August 2022
BASTERRA PP, Nombela F, Iriarte P, Del Rincon CR, et al Proprioceptive Stimuli as a New Type of Trigger for Epilepsy in Stiff Person
Syndrome.
Neurology. 2022 Aug 31. pii: WNL.0000000000201196. PubMed